Lowering the dose of anti-cancer drugs well below the standard treatment threshold has shown promise in improving tumours’ response to...
Vous n'êtes pas connecté
Lowering the dose of anti-cancer drugs well below the standard treatment threshold has shown promise in improving tumours’ response to immunotherapy, new research has found.
Lowering the dose of anti-cancer drugs well below the standard treatment threshold has shown promise in improving tumours’ response to...
Immune checkpoint blockade (ICB) is one of the primary methods of tumour immunotherapy. It involves reactivating the immune system, which cancer has...
Researchers described results as 'an important first step' in potentially developing new treatment for people with advanced cancers.
MONDAY, Sept 16, 2024 -- A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with advanced...
Immune checkpoint inhibitors (ICIs) are a class of immunotherapy that have revolutionized the treatment of cancer.
Scientists have made a major breakthrough in neuroscience, developing a novel RNA-based nasal spray, COG-201, that has shown remarkable promise in...
In contrast to other commonly diagnosed cancers like colorectal and lung cancer, the 5-year survival rate after diagnosis for pancreatic cancer is...
WEDNESDAY, Sept. 18, 2024 -- Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients,...
In a new study, clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) have demonstrated the use of exosomes to...
Immunotherapy is a type of cancer treatment that uses the body's own immune system to help fight cancer. This is by stimulating the immune response to...